Let-7c-5p down-regulates immune-related CDCA8 to inhibit hepatocellular carcinoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Let-7c-5p down-regulates immune-related CDCA8 to inhibit hepatocellular carcinoma
Authors
Keywords
-
Journal
FUNCTIONAL & INTEGRATIVE GENOMICS
Volume 23, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-02-04
DOI
10.1007/s10142-023-00974-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial
- (2022) Gontran Verset et al. CLINICAL CANCER RESEARCH
- Let-7c-5p Restrains Cell Growth and Induces Apoptosis of Lung Adenocarcinoma Cells via Targeting ESPL1
- (2022) Xiang Liu et al. MOLECULAR BIOTECHNOLOGY
- Comparison of nivolumab and sorafenib for first systemic therapy in patients with hepatocellular carcinoma and Child‐Pugh B cirrhosis
- (2022) William J. Chapin et al. Cancer Medicine
- Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
- (2022) Ahmed Omar Kaseb et al. Lancet Gastroenterology & Hepatology
- MiR-26a-5p regulates proliferation, apoptosis, migration and invasion via inhibiting hydroxysteroid dehydrogenase like-2 in cervical cancer cell
- (2022) Ming Li et al. BMC CANCER
- GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels
- (2022) Chun-Jie Liu et al. BRIEFINGS IN BIOINFORMATICS
- Plasma miRNAs improve the prediction of coronary atherosclerosis in patients with rheumatoid arthritis
- (2021) Michelle J. Ormseth et al. CLINICAL RHEUMATOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Silencing CDCA8 Suppresses Hepatocellular Carcinoma Growth and Stemness via Restoration of ATF3 Tumor Suppressor and Inactivation of AKT/β–Catenin Signaling
- (2021) Taewon Jeon et al. Cancers
- Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
- (2021) Zhenggang Ren et al. LANCET ONCOLOGY
- Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
- (2021) Thomas Yau et al. LANCET ONCOLOGY
- Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis
- (2021) Marta Correia de Sousa et al. Cancers
- Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study
- (2020) Chenwei Wang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Early and Late Recurrence of Hepatitis B Virus–Associated Hepatocellular Carcinoma
- (2020) Ming‐Da Wang et al. ONCOLOGIST
- Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacokinetic and pharmacodynamic factors contribute to synergism between let-7c-5p and 5-fluorouracil in inhibiting hepatocellular carcinoma cell viability
- (2020) Joseph L. Jilek et al. DRUG METABOLISM AND DISPOSITION
- TISIDB: an integrated repository portal for tumor-immune system interactions
- (2019) Beibei Ru et al. BIOINFORMATICS
- Potential Relationship between Clinical Significance and Serum Exosomal miRNAs in Patients with Multiple Myeloma
- (2019) Zhi-yao Zhang et al. Biomed Research International
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
- (2018) Jianfang Liu et al. CELL
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Let-7c-5p inhibits cell proliferation and induces cell apoptosis by targeting ERCC6 in breast cancer
- (2017) Xiaonan Fu et al. ONCOLOGY REPORTS
- Circulating cell-free miRNAs as biomarker for triple-negative breast cancer
- (2015) V Y Shin et al. BRITISH JOURNAL OF CANCER
- miR-Test: A Blood Test for Lung Cancer Early Detection
- (2015) Francesca Montani et al. JNCI-Journal of the National Cancer Institute
- miR-Test: A Blood Test for Lung Cancer Early Detection
- (2015) Francesca Montani et al. JNCI-Journal of the National Cancer Institute
- starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data
- (2013) Jun-Hao Li et al. NUCLEIC ACIDS RESEARCH
- A Brief Review on the Mechanisms of miRNA Regulation
- (2010) Yimei Cai et al. GENOMICS PROTEOMICS & BIOINFORMATICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started